The Wake Forest Institute of Regenerative Medicine — Winston-Salem, North Carolina

The Wake Forest Institute of Regenerative Medicine is a clinical research site located in Winston-Salem, North Carolina, United States 27101.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

The Wake Forest Institute of Regenerative Medicine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Interstitial Cystitis, Bladder Pain Syndrome.

Sponsors: Vaneltix Pharma, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Winston-Salem

Browse all research sites in North Carolina · View every site in Winston-Salem

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Wake Forest Institute of Regenerative Medicine?

The Wake Forest Institute of Regenerative Medicine has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Wake Forest Institute of Regenerative Medicine conducted?

The Wake Forest Institute of Regenerative Medicine has 1 clinical trials on record, with 1 currently active. Their work covers Interstitial Cystitis, Bladder Pain Syndrome.

Is The Wake Forest Institute of Regenerative Medicine accredited by Crixeo Clinical Trials?

The Wake Forest Institute of Regenerative Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Wake Forest Institute of Regenerative Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.